Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Tew

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Gynecologic Oncology Reports|June 6, 2022
Multiple isolated ovarian cancer recurrences in the cervix and vagina after supracervical hysterectomy: A case reportAnh Q Nguyen, Sarah Ehmann, Jaqueline Feinberg, et al.
Acta Biomaterialia|October 8, 2013
Thiolated hyaluronan-based hydrogels crosslinked using oxidized glutathione: an injectable matrix designed for ophthalmic applicationsThomas I Zarembinski, Nathaniel J Doty, Isaac E Erickson, et al.
Future Oncology (London, England)|June 27, 2019
Utilization of tumor genomics in clinical practice: an international survey among ASCO membersRomualdo Barroso-Sousa, Hao Guo, Piyush Srivastava, et al.
Gynecologic Oncology|June 27, 2013
Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancerSarah A Milgrom, Marisa A Kollmeier, Nadeem R Abu-Rustum, et al.
Annals of Surgery|June 3, 2014
Geriatric Assessment as a Predictor of Delirium and Other Outcomes in Elderly Patients With CancerBeatriz Korc-Grodzicki, Sung W Sun, Qin Zhou, et al.
Investigational New Drugs|October 29, 2008
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancerWilliam P Tew, Delia Radovich, Eileen O'Reilly, et al.
Gynecologic Oncology|December 1, 2009
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatmentRoisin O'Cearbhaill, Qin Zhou, Alexia Iasonos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2016
A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerKatherine M Bell-McGuinn, Jason A Konner, William P Tew, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 15, 2013
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancerElizabeth Won, Arti Hurria, Tao Feng, et al.
Gynecologic Oncology|May 19, 2007
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapyEric L Eisenhauer, William P Tew, Douglas A Levine, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Gynecologic Oncology Reports|June 6, 2022
Multiple isolated ovarian cancer recurrences in the cervix and vagina after supracervical hysterectomy: A case reportAnh Q Nguyen, Sarah Ehmann, Jaqueline Feinberg, et al.
Acta Biomaterialia|October 8, 2013
Thiolated hyaluronan-based hydrogels crosslinked using oxidized glutathione: an injectable matrix designed for ophthalmic applicationsThomas I Zarembinski, Nathaniel J Doty, Isaac E Erickson, et al.
Future Oncology (London, England)|June 27, 2019
Utilization of tumor genomics in clinical practice: an international survey among ASCO membersRomualdo Barroso-Sousa, Hao Guo, Piyush Srivastava, et al.
Gynecologic Oncology|June 27, 2013
Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancerSarah A Milgrom, Marisa A Kollmeier, Nadeem R Abu-Rustum, et al.
Annals of Surgery|June 3, 2014
Geriatric Assessment as a Predictor of Delirium and Other Outcomes in Elderly Patients With CancerBeatriz Korc-Grodzicki, Sung W Sun, Qin Zhou, et al.
Investigational New Drugs|October 29, 2008
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancerWilliam P Tew, Delia Radovich, Eileen O'Reilly, et al.
Gynecologic Oncology|December 1, 2009
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatmentRoisin O'Cearbhaill, Qin Zhou, Alexia Iasonos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2016
A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerKatherine M Bell-McGuinn, Jason A Konner, William P Tew, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 15, 2013
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancerElizabeth Won, Arti Hurria, Tao Feng, et al.
Gynecologic Oncology|May 19, 2007
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapyEric L Eisenhauer, William P Tew, Douglas A Levine, et al.
Pageof 12